Predicted Trait | |
Reported Trait | Lymphocytic leukemia |
Mapped Trait(s) | lymphoid leukemia (EFO_0004289) |
Score Construction | |
PGS Name | CC_LL |
Development Method | |
Name | Genome-wide significant variants |
Parameters | P < 5e-8, MAF > 1%, biallelic SNPs, LD-thin r2 > 0.3 |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 75 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000050 |
Citation (link to publication) | Graff RE et al. Nat Commun (2021) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | |
PGS Evaluation | European: 100% 3 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST003468 Europe PMC: 26956414 |
10,767 individuals | European | NR |
GWAS Catalog: GCST002073 Europe PMC: 23770605 |
8,400 individuals | European | NR |
GWAS Catalog: GCST005965 Europe PMC: 29296818 |
3,220 individuals | European | NR |
GWAS Catalog: GCST000224 Europe PMC: 18758461 |
1,943 individuals | European | B58C |
GWAS Catalog: GCST001320 Europe PMC: 22076464 |
893 individuals | European | NR |
GWAS Catalog: GCST002657 Europe PMC: 25310577 |
1,550 individuals | European | NR |
GWAS Catalog: GCST004146 Europe PMC: 28165464 |
17,691 individuals | European | NR |
GWAS Catalog: GCST004099 Europe PMC: 28112199 |
14,421 individuals | European | NR |
GWAS Catalog: GCST002236 Europe PMC: 24141364 |
4,344 individuals | African American or Afro-Caribbean, Asian unspecified | COG |
GWAS Catalog: GCST002236 Europe PMC: 24141364 |
1,541 individuals | European | COG |
GWAS Catalog: GCST002236 Europe PMC: 24141364 |
1,287 individuals | Hispanic or Latin American | COG |
GWAS Catalog: GCST000463 Europe PMC: 19684604 |
3,305 individuals | European | NR |
GWAS Catalog: GCST002299 Europe PMC: 24292274 |
6,938 individuals | European | UK-CLL |
GWAS Catalog: GCST000464 Europe PMC: 19684603 |
19,275 individuals | European | COG, GAIN, SJCRH, WTCCC |
GWAS Catalog: GCST003798 Europe PMC: 27694927 |
8,882 individuals | European | NR |
GWAS Catalog: GCST005832 Europe PMC: 29632299 |
17,051 individuals | European | NR |
GWAS Catalog: GCST005315 Europe PMC: 29348612 |
3,972 individuals | African American or Afro-Caribbean | NR |
GWAS Catalog: GCST005315 Europe PMC: 29348612 |
4,735 individuals | European | NR |
GWAS Catalog: GCST005315 Europe PMC: 29348612 |
10,533 individuals | Hispanic or Latin American | NR |
GWAS Catalog: GCST001912 Europe PMC: 23512250 |
1,452 individuals | African American or Afro-Caribbean | MESA |
GWAS Catalog: GCST001912 Europe PMC: 23512250 |
1,313 individuals | Hispanic or Latin American | MESA |
GWAS Catalog: GCST001912 Europe PMC: 23512250 |
2,358 individuals | European | MESA |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM000197 | PSS000116| European Ancestry| 411,207 individuals |
PGP000050 | Graff RE et al. Nat Commun (2021) |
Reported Trait: Lymphocytic leukemia | OR: 1.42 [1.33, 1.51] | — | — | Genotyping reagent kit (GERA cohort only), genotyping array (UK Biobank only), age, sex, 10 PCs. | Results from meta-analysis of GERA and UKB |
PPM002043 | PSS001016| European Ancestry| 391,338 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |Ext. |
Reported Trait: Incident Lymphocytic Leukemia | HR: 1.45 [1.31, 1.61] | AUROC: 0.719 C-index: 0.735 (0.016) |
— | Age at assessment, sex, genotyping array, PCs(1-15) | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
PPM017175 | PSS010147| European Ancestry| 246 individuals |
PGP000443 | Byrne S et al. Int J Epidemiol (2023) |Ext. |
Reported Trait: Lymphocytic leukemia | HR: 1.5 [1.33, 1.69] | — | — | age at baseline, sex (where relevant), assessment centre, 40 principal components of ancestries (PCs), Townsend Index, education, birth location, income, lifestyle index | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS010147 | — | — | [
|
— | European | — | UKB | — |
PSS000116 | Cancer diagnoses were obtained from reigstry data in GERA, and ICD-9/10 codes mapped to ICD-O-3 codes in UK Biobank. Cancers for this phenotype were classified using the following SEER site recode(s): 35011 - 35013 | — | [ ,
46.0 % Male samples |
Mean = 58.0 years | European | — | GERA, UKB | — |
PSS001016 | Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases. | — | [
|
— | European | — | UKB | — |